2-methyl-thiobenzoic acid | 50684-47-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-methyl-thiobenzoic acid
• 英文别名: 2-methylbenzenecarbothioic S-acid
• CAS: 50684-47-4
• 化学式: C₈H₈OS
• mdl: MFCD11519065
• 分子量: 152.217
• InChiKey: BHJWUUSAMQADIT-UHFFFAOYSA-N

物化性质

• 沸点：
  254.3±23.0 °C(Predicted)
• 密度：
  1.129±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  18.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-methyl-thiobenzoic acid 在 potassium hydroxide 、 hydroxylamine-O-sulfonic acid 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 12.08h， 生成 S-benzamido 2-methylbenzenecarbothioate
  参考文献：
  名称：

  Design, Synthesis, and Cardioprotective Effects of N-Mercapto-Based Hydrogen Sulfide Donors

  摘要：

  Hydrogen sulfide (H2S) is a signaling molecule which plays regulatory roles in many physiological and/or pathological processes. Therefore, regulation of H2S levels could have great potential therapeutic value. In this work, we report the design, synthesis, and evaluation of a class of N-mercapto (N-SH)-based H2S donors. Thirty-three donors were synthesized and tested. Our results indicated that controllable H2S release from these donors could be achieved upon structural modifications. Selected donors (NSHD-1, NSHD-2, and NSHD-6) were tested in cellular models of oxidative damage and showed significant cytoprotective effects. Moreover, NSHD-1 and NSHD-2 were also found to exhibit potent protective effects in a murine model of myocardial ischemia reperfusion (MI/R) injury.

  DOI：

  10.1021/acs.jmedchem.5b01033
• 作为产物：
  描述：

  methyl {2-[(trimethylsilyl)oxy]phenyl}acetate 生成 2-methyl-thiobenzoic acid
  参考文献：
  名称：

  Aryl thiopyrano[2,3,4-C,D]indoles as inhibitors of leukotriene

  摘要：

  具有I式化合物的化合物：##STR1##是5-脂氧合酶的抑制剂和白细胞三烯生物合成的抑制剂。这些化合物可用作抗哮喘、抗过敏、抗炎和细胞保护剂。它们还有助于治疗心绞痛、脑血管痉挛、肾小球肾炎、肝炎、内毒素血症、银屑病、葡萄膜炎和异体移植排斥，并预防动脉粥样硬化斑块的形成。

  公开号：

  US05314900A1

文献信息

• 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as
  申请人：Warner-Lambert Company

  公开号：US05652237A1

  公开（公告）日：1997-07-29

  This invention concerns certain 2-substituted-3,1-benzoxazin-4-ones and benzthiazinones as complement Clr protease inhibitors and antiinflammatory agents, pharmaceutical compositions containing them, methods of using them, and processes for their preparation.

  这项发明涉及某些2-取代-3,1-苯并噁嗪-4-酮和苯并噻嗪酮作为补体Clr蛋白酶抑制剂和抗炎药物，包含它们的药物组合物，使用它们的方法以及它们的制备方法。
• [EN] CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF<br/>[FR] DÉRIVÉS DE CALICHÉAMICINE ET CONJUGUÉS ANTICORPS-MÉDICAMENTS DE CEUX-CI
  申请人：PFIZER

  公开号：WO2018138591A1

  公开（公告）日：2018-08-02

  The present invention is directed to novel calicheamicin derivatives useful as payloads in antibody-drug-conjugates (ADC's), and to payload-linker compounds and ADC compounds comprising the same; to pharmaceutical compositions comprising the same and to methods for using the same to treat pathological conditions such as cancer.

  本发明涉及新型calicheamicin衍生物，用作抗体-药物偶联物（ADC）的有效载荷，以及包含相同有效载荷-连接剂化合物和ADC化合物；涉及包含它们的药物组合物以及使用它们治疗诸如癌症等病理状态的方法。
• 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine
  申请人：Merckle GmbH

  公开号：US06432988B1

  公开（公告）日：2002-08-13

  The invention relates to 4-heteroaryl-5-phenylimidazole derivatives having 2-arylalkylthio, 2-arylalkenylthio and 2-arylalkynylthio substitution, of the general formula I: in which Ar is a phenyl radical, Het is a hetero aromatic radical, A is an alkylene chain, R1 is an alkylthio, alkylsulfinyl, alkylsulfonyl, sulfonamido or alkylcarbonyl group and R2 is an alkyl, hydroxyl, alkoxy, alkoxycarbonyl, sulfonamido, carboxyl, nitro or aminocarbonyl group or a halogen atom. n can be 1 or 2 and m is 0 to 2. The compounds according to the invention show antiinflammatory activity.

  该发明涉及具有2-芳基烷硫基，2-芳基烯基硫基和2-芳基炔基硫基取代的4-杂环芳基-5-苯基咪唑衍生物，其一般式为I： 其中Ar是苯基基团，Het是杂环芳基基团，A是烷基链，R1是烷硫基，烷砜基，烷砜基，磺胺基或烷基羰基基团，R2是烷基，羟基，烷氧基，烷氧羰基，磺胺基，羧基，硝基或氨基羰基基团或卤原子。n可以是1或2，m为0至2。根据该发明的化合物表现出抗炎活性。
• 1,2-DIAZETIDIN-3-ONE DERIVATIVES AND DRUGS CONTAINING SAME
  申请人：Nakashima Hisashi

  公开号：US20100144694A1

  公开（公告）日：2010-06-10

  [Object] It is to provide a novel compound useful for preventing and/or treating diseases that involves 11β-hydroxysteroid dehydrogenase 1 (in particular diabetes, insulin resistance, diabetes complication, obesity, dyslipidemia, hypertension, fatty liver, or metabolic syndrome). [Means to Solve the Object] A 1,2-diazetidin-3-one derivative represented by the following general formula (1) or salt thereof, or their solvate.

  提供一种新型化合物，用于预防和/或治疗涉及11β-羟基类固醇脱氢酶1（特别是糖尿病、胰岛素抵抗、糖尿病并发症、肥胖、血脂异常、高血压、脂肪肝或代谢综合征）的疾病。通过以下一般式（1）所代表的1,2-二氮杂环丙酮衍生物或其盐，或其溶剂化合物来解决该问题。
• Catalyst- and organic solvent-free synthesis of thioacids in water
  作者：Mohamed Elagawany、Lamees Hegazy、Bahaa Elgendy

  DOI：10.1016/j.tetlet.2019.06.061

  日期：2019.7

  acyl benzotriazoles and sodium hydrosulfide in water at room temperature. The new methodology features mild reaction conditions, high yields, short reaction times, and does not involve the use of organic solvents or bases. The reaction is eco-friendly, and the workup procedure is simple and does not require chromatographic separation.

  在室温下，由水中易得的酰基苯并三唑和氢硫化钠可高产率合成硫代酸和硫代氨基酸。新方法的特点是反应条件温和，收率高，反应时间短，并且不涉及有机溶剂或碱的使用。该反应是环境友好的，并且后处理步骤简单并且不需要色谱分离。